Diamond Hill Capital Management, LLC on Stryker Corporation
Thesis
Diamond Hill bought Stryker for its position in surgical instruments, medical devices and implants across orthopedics and neurovascular care. A broad product set and consistent innovation provide scope for gaining market share. The company’s commercial execution strengthens the manager’s confidence that revenue growth can outpace its end markets. The holding adds a high-quality healthcare compounder to the repositioned portfolio.
“position Stryker to continue gaining market share and delivering above-market growth.”
Key risks
- Market-share gains could fall short if commercial execution weakens
- Innovation and new product adoption must sustain above-market growth